SELECT PUBLICATIONS
Ajani J et al. Intergroup RTOG 98-11: A phase III randomized study of 5-fluorouracil (5-FU), mitomycin, and radiotherapy versus 5-fluorouracil, cisplatin and radiotherapy in carcinoma of the anal canal. Proc ASCO 2006; Abstract 4009.
Cassidy J et al. XELOX compared to FOLFOX4: Survival and response results from XELOX-1/NO16966, a randomized phase III trial of first-line treatment for patients with metastatic colorectal cancer (MCRC). Proc ASCO 2007;Abstract 4030.
Das P et al. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis. Int J Radiat Oncol Biol Phys 2006;66(5):1378-83. Abstract
Eng C et al. A Phase II study of capecitabine plus oxaliplatin and radiation therapy, XELOX-XRT, in squamous cell carcinoma (SCCA) of the anal canal: A preliminary analysis. Proc ASCO 2005;Abstract 4271.
Giantonio B et al. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: Results from the Eastern Cooperative Oncology Group Study E3200. J Clin Oncol 2007;25(12):1539-44. Abstract
Haller D et al. Tolerability of fluoropyrimidines appears to differ by region. Proc ASCO 2006;Abstract 3514.
Love N et al. Patient perspectives on adjuvant systemic therapy of early colorectal cancer. Cancer Q & A 2007;1(1):10-1. Available at: www.CancerQandA.com
Tabernero J et al. An international phase II study of cetuximab in combination with oxaliplatin/5-fluorouracil (5-FU)/folinic acid (FA) (FOLFOX-4) in the first-line treatment of patients with metastatic colorectal cancer (CRC) expressing Epidermal Growth Factor Receptor (EGFR). Preliminary results. Proc ASCO 2004;Abstract 3512.
Willett CG et al. Complete pathological response to bevacizumab and chemoradiation in advanced rectal cancer. Nat Clin Pract Oncol 2007a;4(5):316-21. Abstract
Willett C et al.
Phase I/II study of neoadjuvant bevacizumab with radiation therapy and 5- fluorouracil in patients with rectal cancer: Initial results. Proc ASCO 2007b;
Abstract 4041.
